| Product Code: ETC10079505 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Neurodegenerative Disease Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Neurodegenerative Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Neurodegenerative Disease Market - Industry Life Cycle |
3.4 Vietnam Neurodegenerative Disease Market - Porter's Five Forces |
3.5 Vietnam Neurodegenerative Disease Market Revenues & Volume Share, By Indication Type, 2021 & 2031F |
3.6 Vietnam Neurodegenerative Disease Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
4 Vietnam Neurodegenerative Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurodegenerative diseases in Vietnam due to aging population |
4.2.2 Growing awareness and diagnosis rates of neurodegenerative diseases |
4.2.3 Advancements in medical technology and treatment options for neurodegenerative diseases |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in remote areas of Vietnam |
4.3.2 High treatment costs associated with neurodegenerative diseases |
4.3.3 Lack of healthcare infrastructure and resources for managing neurodegenerative diseases effectively |
5 Vietnam Neurodegenerative Disease Market Trends |
6 Vietnam Neurodegenerative Disease Market, By Types |
6.1 Vietnam Neurodegenerative Disease Market, By Indication Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Neurodegenerative Disease Market Revenues & Volume, By Indication Type, 2021- 2031F |
6.1.3 Vietnam Neurodegenerative Disease Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F |
6.1.4 Vietnam Neurodegenerative Disease Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F |
6.1.5 Vietnam Neurodegenerative Disease Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.6 Vietnam Neurodegenerative Disease Market Revenues & Volume, By Huntington Disease, 2021- 2031F |
6.1.7 Vietnam Neurodegenerative Disease Market Revenues & Volume, By Other Indication Types, 2021- 2031F |
6.2 Vietnam Neurodegenerative Disease Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Neurodegenerative Disease Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F |
6.2.3 Vietnam Neurodegenerative Disease Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F |
6.2.4 Vietnam Neurodegenerative Disease Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F |
6.2.5 Vietnam Neurodegenerative Disease Market Revenues & Volume, By Immunomodulatory Drugs, 2021- 2031F |
6.2.6 Vietnam Neurodegenerative Disease Market Revenues & Volume, By Other Drug Types, 2021- 2031F |
7 Vietnam Neurodegenerative Disease Market Import-Export Trade Statistics |
7.1 Vietnam Neurodegenerative Disease Market Export to Major Countries |
7.2 Vietnam Neurodegenerative Disease Market Imports from Major Countries |
8 Vietnam Neurodegenerative Disease Market Key Performance Indicators |
8.1 Number of neurologists and healthcare professionals specializing in neurodegenerative diseases in Vietnam |
8.2 Adoption rate of cutting-edge technologies and treatments for neurodegenerative diseases in healthcare facilities |
8.3 Percentage increase in government funding towards research and development of neurodegenerative disease treatments |
8.4 Patient satisfaction and quality of life improvements post-treatment for neurodegenerative diseases |
9 Vietnam Neurodegenerative Disease Market - Opportunity Assessment |
9.1 Vietnam Neurodegenerative Disease Market Opportunity Assessment, By Indication Type, 2021 & 2031F |
9.2 Vietnam Neurodegenerative Disease Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10 Vietnam Neurodegenerative Disease Market - Competitive Landscape |
10.1 Vietnam Neurodegenerative Disease Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Neurodegenerative Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here